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Sample title
Cholesterol Content in the Membrane Promotes Key Lipid-Protein
Interactions in a Pentameric Serotonin-Gated Ion Channel
Alessandro Crnjar1, a) and Carla Molteni1, b)
Physics Department, King’s College London, Strand, London WC2R 2LS, United Kingdom.
(Dated: 10 October 2020)
Pentameric ligand-gated ion channels (pLGICs), embedded in the lipid membranes of nerve cells, mediate fast synaptic
transmission and are major pharmaceutical targets. Because of their complexity and the limited knowledge of their
structure, their working mechanisms have still to be fully unravelled at the molecular level. Over the past years,
evidence that the lipid membrane may modulate the function of membrane proteins, including pLGICs, has emerged.
Here we investigate, by means of molecular dynamics simulations, the behaviour of the lipid membrane at the interface
with the 5-HT3A receptor (5-HT3AR), a representative pLGIC which is the target of nausea-suppressant drugs, in a non-
conductive state. Three lipid compositions are studied, spanning different concentrations of the phospholipids POPC
and POPE and of cholesterol, hence a range of viscosities. A variety of lipid interactions and persistent binding events to
different parts of the receptor are revealed in the investigated models, providing snapshots of the dynamical environment
at the membrane-receptor interface. Some of these events result in lipid intercalation within the transmembrane domain
and others reach out to protein key sections for signal transmission and receptor activation, such as the Cys-loop and
the M2-M3 loop. In particular, phospholipids, with their long hydrophobic tails, play an important role role in these
interactions, potentially providing a bridge between these two structures. A higher cholesterol content appears to
promote lipid persistent binding to the receptor.
I. INTRODUCTION
Pentameric ligand-gated ion channels (pLGICs) are in-
volved in fast synaptic transmission and, as such, are crucial
drug targets, often investigated for the development of novel
pharmaceuticals. These neuroreceptors are embedded in the
lipid membrane of nerve cells, and they have characteristic
structural features: they are made up of five subunits around
an ion-permeable channel, divided into an extracellular do-
main (ECD), a transmembrane domain (TMD) and often an
intracellular domain (ICD). The binding of neurotransmitters
at the interface between subunits in the ECD is associated with
the opening of the channel within the TMD, thus allowing the
flux of ions between the extracellular environment and the cy-
tosol of the cell.1,2 Many open questions still remain about
the mechanistic functioning of these proteins, in particular re-
lated to the transmission of the mechanical signal, initiated by
neurotransmitter binding, which triggers the opening (gating)
of the channel. Despite the recent increasing number of good
resolution X-ray and cryo-electron microscopy structures (ei-
ther of full or partial length, apo or bound, and in different
functional states),3–16 addressing these issues is far from triv-
ial due to protein complexity.
While the ligand orthosteric binding to the ECD remains the
ultimate trigger for channel gating, there is growing evidence
that the lipid membrane may contribute to the overall mecha-
nisms through the interactions at the membrane-receptor in-
terface. Lipids interactions have been suggested to affect
structural and dynamical features in several membrane pro-
teins. These include pLGICs,17,18 such as the nicotinic acetyl-
choline receptor (nAChR) which has been the most studied
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in this context,19–25the 5-hydroxytryptamine type 3A receptor
(5-HT3AR),26 the GABAA receptor,27 the Glycine receptor,28
the prokaryotic Erwinia chrysantemi (ELIC) ion channel29–31
and Gloeobacter violaceous (GLIC) receptor,32,33 as well
as G-protein coupled receptors (GPCRs),34–37 mechanosensi-
tive channels,38, amyloid precursor proteins,39 heterotrimeric
G proteins,39,40 and others. However, the mechanisms un-
derlying these lipid-modulated effects in pLGICs are still
poorly understood;18 hence, additional investigations, includ-
ing atomistic simulations, are needed to build a reliable pic-
ture at the molecular level, especially in cases where very few
studies have been performed so far, such as for the 5-HT3A
receptor.26
The cell membrane is very complex to model, with the
“average” human membrane estimated to contain over 60
lipid species.41 Although great progress has been made in
realistically modelling the cell membrane at various levels
of resolution (from atomistic to coarse grained and super
coarse grained),42 even simplified models, going beyond a
single lipid species, pose challenges to state-of-the-art sim-
ulations, but can provide interesting preliminary insights into
the receptor-membrane interface.
Phospholipids, as well as cholesterol (CHL), are major
components of animal cell membranes. In particular, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)
and 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
(POPE) are prevalent phosphatidylcholines and phos-
phatidylethanolamines respectively. POPC, POPE and CHL
are represented in Fig. 1. POPC is a neutral phospholipid
made up of two hydrophobic tails joined to a hydrophilic
head group which incorporates a choline, and only differs
from POPE in the head group, which for the latter con-
sists of an ethanolamine. Thus, POPC and POPE have
different abilities to form hydrogen bonds. This has been
demonstrated to affect, among others, the structural confor-




























































































FIG. 1. Structure of POPC (left), POPE (centre), and cholesterol
(CHL, right).
channel, in molecular dynamics (MD) simulations of such
protein embedded in POPE membranes, manually turned
into POPC during the simulation.38 Pure-POPC membrane
have also been proved, by means of single-particle cryo-
electron microscopy, to decouple the ECD and the TMD
of ELIC, thus preventing the mechanical signal induced
by agonist binding to propagate into the latter; POPC
polar heads were found responsible, as supported by MD
simulations, of lipid-protein interactions which affect the
closed-open-desensitized equilibrium constants.29 Native
mass spectrometry, coarse-grained simulations and functional
assays found the glycerophospholipid POPG binding to
ELIC responsible for the stabilization of its open state with
respect to the desensitized state.30 Receptor reconstruction in
high-density-lipoparticles of a GPCR proved how the head
group of phospholipids can affect agonist and antagonist
binding and receptor activation.37 A comparison of the X-ray
structures of the Caenorhabditis elegans glutamate-gated
chloride channel (GluCl) in apo-state and in a POPC-bound
state revealed how lipids can potentiate agonist binding
and promote an expanded open-like conformation of the
transmembrane domain.7 The combination of POPC and
POPE phospholipids (with the addition of CHL) has been
extensively used in-silico works26,33–35,38,43,44. It is a good
exploratory minimal but representative choice, and is used
here, although it is not unique. In fact, other choices are
possible, for example by considering phospholipids with
the same head group but different hydrophobic tails, like
POPC and SDPC26, or more complex compositions within a
coarse-grained treatment.28
Cholesterol has a much shorter structure than POPC and
POPE, being made up of four aromatic rings, an aliphatic
tail and a hydroxyl group head. It is very important be-
cause it is found in high concentrations in the membranes
of human brain cells.45,46 When present in lipid membranes,
cholesterol modulates membrane fluidity, affecting the lat-
eral diffusion of phospholipids.47 It typically binds to mem-
brane proteins in preferred sites, referred to as “Cholesterol
Recognition/interaction Amino acid Consensus sequence",
or “CRAC" domains, and as “inverted CRAC" (“CARC")
domains.19,48–50 The sequence of CRAC domains is (L/V)-
X1−5-(Y)-X1−5-(K/R) in the N-terminus to C-terminus direc-
tion, where L/V is either a leucine or a valine, X1−5 is any
number between 1 and 5 of any amino-acid, Y is a tyrosine,
and K/R is either a lysine or an arginine. The sequence of
the CARC domain is instead (K/R)-X1−5-(Y/F)-X1−5-(L/V),
from the N-terminus to the C-terminus. Cholesterol is able to
affect various features of membrane proteins. For example, in
the G-protein coupled 5-HT1B receptor, its interaction with a
transmembrane helix was found to modify the serotonin bind-
ing mode in the extracellular pocket by MD simulations.44 In
the 5-HT3A receptor, microseconds-long simulations showed
that cholesterol, with phospholipids POPC and SDPC, was
able to penetrate into one subunit of the TMD during rear-
rangements upon serotonin-binding, contributing to the sta-
bilization of an alleged pre-active state (i.e. a conformation
which resembles an initial stage of channel opening), support-
ing its necessity in contrast to pure-POPC membranes.26 In
the adenosine type 2A receptor, cholesterol binding was found
to affect, in in-silico studies, the binding poses of caffeine
and its mobility in the pocket.43. Other in-silico investigations
suggested that cholesterol binding may promote pore opening
in the GABAA receptor27 and is necessary for the structure
preservation of the nicotinic acetylcholine receptor by pro-
moting contacts between the ligand-binding domain and the
pore.21
A conspicuous literature on pLGICs also suggests that the
outermost M4 helix may act as a lipid sensor. This is the case
of the nicotinic acetylcoline receptor, whose M4/Cys-loop in-
teractions were suggested to be favoured by lipid-dependent
properties through experimental characterisation.24 Also in
nAChR, the thickness of phosphatidylcholine membranes was
experimentally shown to affect transitions between uncoupled
and coupled conformations.25 In ELIC, the M4 helix carries
a lipid-binding site, whose disruption accelerates desensitiza-
tion, as pointed out by mutagenesis experiments.31
Overall, the consensus is that various types of lipids, in
particular phospholipids and cholesterol, are able to affect
the function of a variety of membrane proteins, including
pLGICs, because of their ability to bind to them, and thus
act as potential mediators between different protein domains
and/or alter the properties of such domains.
Here, we investigated, for different lipid compositions, the
interface between model membranes and the 5-HT3A receptor
(5-HT3AR), an important pLGIC which is involved in neuro-
logical diseases such as schizofrenia, Alzheimer’s and many
others, and is the target of nausea-suppressant drugs. This re-
ceptor belongs to the Cys-loop superfamily of pLGICs, which
takes its name from the highly conserved Cys-loop at the in-
terface between ECD and TMD. We carried out this study via
all-atom MD simulations, with a pure-POPC membrane and
two POPC-POPE-CHL mixed membranes of increasing vis-
cosity. We characterized the interface between the receptor
and the lipid membrane, through analysis of the occurrence
of their interactions and the lipids proximity lifetime distri-




























































































of which involved lipid intercalation within the protein and/or
interactions with relevant protein sections. We showed how
cholesterol, which increases the viscosity of the lipid mem-
brane, promotes lipid binding to the protein. We also showed
how phospholipids may act as bridges between key protein
sections, such as the Cys-loop and the M2-M3 loop, con-
necting the ECD and the TMD. Most previous MD studies
of the 5-HT3 receptor used single lipid membranes,15,16,51–54
with the exception of a very recent study where a spe-
cific POPC/SPDC/CHL membrane composition was assessed
against POPC and in the presence of neurotransmitters.26
II. METHODS
A homopentameric model of the mouse 5-HT3A receptor
was built from the X-ray apo-structure at 3.5 Å resolution de-
termined by Hassaine et al. (PDB entry: 4PIR)8 and is shown
in Fig.2. The TMD is of particular relevance for the scope of
this work, and is represented in Fig. 2 b) in a view orthogo-
nal to the ion channel: it is made up of 4 helices per subunit,
labelled M1, M2, M3, and M4 according to the progression
alongside the primary sequence. The M1 and M3 helices are
found at the interfaces between adjacent subunits. The M2 he-
lices line the ion channel, and have therefore little chance to
interact with the membrane, while the M4 helices occupy the
outermost position facing the membrane.
The channel size at the hydrophobic gate, and the pres-
ence of Llama-derived single-chain antibodies (VHH) used
to stabilize the structure during crystallization (which act as
antagonists), suggest ions would not pass through and thus
the structure is in a non-conductive state. Four residues in
the M2-M3 loop (Thr276, Ala277, Ile278 and Gly279) were
manually added as they were not resolved experimentally, and
optimized with NQ-flipper, a web-based server for the analy-
sis of rotamers.55 Stabilizing agents and non-native fragments
were not included. The ICD was only partially resolved, so,
to avoid arbitrary reconstructions or imposing constraints, the
terminal MA and MX helices were removed. The removal
of the ICD allows for a considerable speed-up of the calcula-
tions, under the assumption that it does not exert a consider-
able influence on the lipid-protein interactions, which involve
mostly the TMD, in the time scales explored here. The M3
and M4 helices were connected to each other through a short
link of sequence VHKQDLQRD, which originally belonged
to the link between M3 and MX. Its length was chosen so
to match the M4 connection and to resemble the structure of
ICD-lacking pLGICs, such as ELIC and GluCl.
The model was protonated at neutral pH, and embedded in
lipid bilayers with the CHARMM-GUI membrane builder.56
Three different membrane models were built, here labelled
A, B and C: model A contains only POPC, model B con-
tains 35% POPC, 35% POPE and 30% cholesterol, and model
C contains 25% POPC, 25% POPE, and 50% cholesterol.
The resulting membrane areas were about 125 Å by 128 Å
for model A, 122 Å by 123 Å for model B, and 121 Å by
122 Å for model C. The pure-POPC model A is the least
complex, resembles systems previously simulated,51,53,54 and
is thus a reliable standard for the comparison with the two
mixed models. Model B has a 6:7:7 concentration, which
has been used in past simulations of membranes with choles-
terol (6), POPC (7) and a third lipid (7) for the study of sero-
tonin receptors.26,57 Model B represents an intermediate com-
position where cholesterol is present, but the phospholipids
are still predominant. Model C has the highest percentage
of cholesterol, which represents the upper CHL concentra-
tion in synaptic membranes (whose cholesterol content varies
between 33% and 50%),43,45,46 and would also prove useful
for enhancing the sampling of cholesterol-related phenomena.
The viscosity of the lipid bilayers increases from A to C.
The systems were then solvated in orthorhombic supercells,
with a 15 Å buffer of TIP3P water and 0.15 M of Na+ and
Cl− ions to reproduce physiological conditions. The final 5-
HT3AR models contained 183,207 atoms (model A), 182,877
atoms (model B), and 175,904 atoms (model C), including
the ions and the solvent. The preparation procedure described
so far is similar to that we previously used for a model 5-
HT3AR in a POPC bilayer where we studied a trans-cis proline
molecular switch at room temperature.54
The systems were simulated with the NAMD 2.9 MD
package58 and the AMBER ff14SB59 and LIPID14 force-
field.60 The simulation time step was 2 fs, and the bonds
containing hydrogen were constrained with the SHAKE al-
gorithm. Particle Mesh Ewald was used for the electrostatic
interactions and a cut off of 10 Å was employed for the non-
bonded interactions.
The three models initially underwent a minimisation pro-
cedure, a slow heating up to 310 K and a partially restrained
equilibration (with the protein α carbons restrained and the
lipids free to diffuse). This equilibration phase lasted for
100 ns, as prescribed for the equilibration of lipid membranes
whose typical diffusion occur over times of the order of tens to
hundreds of nanoseconds,61,62 and was necessary to preserve
the non-conductive state and avoid unphysical conformational
changes in the mixed membrane systems. The restraints were
subsequently released. A subsequent unrestrained simula-
tion was carried out within the isothermal-isobaric (NPT) en-
semble for each model at a temperature of 310 K, which
is above the gel transition temperature for all lipid species
considered,63,64 and at a pressure of 1 atm. The temperature
was controlled by means of a Langevin thermostat with a col-
lision frequency of 1.0 ps, and the pressure was controlled by
means of a Langevin piston barostat with an oscillation period
of 200 fs and a damping time constant of 100 fs.
For each of the three models, two replicas were carried out,
with no restraints, for the production starting from the same
initial geometries but with different initial velocities: one of
500 ns (RX), and one of 250 ns (RY). As lipids diffuse differ-
ently in separate replicas, this allowed us to explore additional
statistics of the processes of lipid diffusion and lipid-protein
interaction. For both RX and RY, the first 50 ns were excluded
from statistics collection so to mitigate the use of the same
initial geometry and allow for independent equilibration: thus
the production runs lasted 450 ns for RX and 200 ns for RY.
There are different ways to improve statistics when per-




























































































FIG. 2. a) The model of 5-HT3AR embedded in the mixed membrane of model B (35% POPC, 35% POPE and 30% CHL). Pink: POPC heads;
dark green: POPE heads; grey: POPC and POPE tails; orange: cholesterol. The five subunits are numbered in anticlockwise order as 1 in
red, 2 in yellow, 3 in green, 4 in light blue and 5 in blue. b) View, orthogonal to the ion channel, of the transmembrane domain helices: M1
(yellow), M2 (blue), M3 (red) and M4 (purple). The M2-M3 loop is shown in green. The other loops connecting helices are not shown for
simplicity.
cas of shorter simulations. To test whether these two ap-
proaches, in the case of similar computational cost, give quali-
tative similar results for time- and subunit-averaged quantities
for the systems studied here, we performed some analysis over
the average of the 50-to-250 ns time-windows of RX and RY
(RXY400), and over the time window 50-to-450 ns of replica
RX (RX400). Other analysis (specifically those that explicitly
express an observable as a function of time) were performed
over the 50-to-500 ns window of RX (RX450) and over the
50-to-250 ns window of RY (RY200).
Trajectories were sampled every 50 ps and analyzed with
the Cpptraj65 and MDAnalysis66,67 software. Hydrogen bonds
were identified by a donor-acceptor distance smaller than 3.5
Å and by a donor-hydrogen-acceptor angle larger than 120◦.
These values have been used in a variety of previous works in
pLGICs54,68–73 and are the defaults of analysis software such
as MDAnalysis.66,67
III. RESULTS
The stability of the protein was assessed by means of the
root mean square displacement (RMSD) of the backbone
atoms with respect to the first frame of the unrestrained NPT
simulations. Its evolution over time during the unrestrained
dynamics is reported in the Supplementary information (SI)
for the whole receptor, ECD and TMD (SI Figs. 1-3). The
average RMSD over the production run, separately calculated
for RXY400 and RX400, is shown in SI Fig. 4 for different
parts of the protein: the ECD, the TMD, and the protein as a
whole, and for each of the four TMD helices. The sequence
of the substructures was defined as in Ref.8. The three mod-
els result stable, and both averaging methods provide similar
results. A degree of variability was observed among the five
subunits, which reflects statistical sampling and fluctuations
within the isothermal-isobaric ensemble, and different local
lipid environments around the TMD. The models maintained
structural integrity during the simulations.
Since the M4s are the outermost helices, they move more
than the other three types of TMD helices, as expected, with
the largest fluctuations determined by their terminals which
extend outside the membrane. Our 5-HT3A model does not
include the intracellular domain, which being incomplete,
would have produced fairly large fluctuations if left unre-
strained.
The lipid bilayers of three models exhibit the expected rel-
ative viscosities, as qualitatively shown by the lipid lateral
mean square displacements (MSD) in SI Fig. 5: model C
is the most viscous, having the highest content of cholesterol,
while model A is the least viscous. Lateral diffusion coeffi-
cients were evaluated via Einstein’s equation providing values
of the order of µm2s−1, in agreement with previous calcula-
tions of lipid systems.20,74,75 The absolute values are affected
by the use of Langevin dynamics, time-scale, size of the mem-
brane and presence of the embedded protein.
In order to characterise in details the protein-membrane
interface, we calculated the distributions of proximity life-




























































































ceptor transmembrane domain (Fig. 3), as the lipids charac-
terised by high proximity lifetimes form the most stable in-
teractions with the protein. Since the lifetimes depend on the
specific replica, these distributions were separately calculated
for RX450 and RY200. We considered multiple time win-
dows shifted by 5 ns, and calculated averages and standard
deviations for each 5 ns time period. The statistics available
for each residence time decreases for larger times.
FIG. 3. Proximity lifetimes of any lipid in close proximity to the
TMD in model A (blue), model B (orange) and model C (green) for
RX450 (top) and RY200 (bottom).
The distributions for the three models decay fast well be-
fore 50 ns, implying that very few lipids spend relatively long
times close to the protein. However, the value of the his-
togram corresponding to the longest time sampled is higher,
which means that a certain amount of lipids spent the en-
tire production time attached to the receptor. These lipids
were further investigated: SI Figs. 6 to 11 show their root
mean square fluctuations (RMSF) for the three models, cal-
culated over RX450 and RY200 with respect to their aver-
age positions. The RMSFs of phospholipids were calculated
separately for the head and the two tails, as each of these
parts may display different mobility due to specific interac-
tions with or hindrance by the protein and/or other lipids. The
investigated lipids are characterised by different RMSF val-
ues, ranging from about 1.5 to about 8.5 Å. Their number
varies both among models and between replicas. The number
of lipid residues that stay attached for the whole production
to the protein, and at the same time are characterized by low
fluctuations (i.e. smaller than 3.0 Å), are shown in Table I.
TABLE I. Number pf lipids (Nlipids), with RSMF smaller than 3.0
Å, attached to the protein for the whole production run in the RX450
and RY200 replicas for models A, B and C.
Model Lipid Species Nlipids (RX450) Nlipids (RY200)












Binding events are specific of the sampling of the
isothermal-isobaric ensemble due to the stochastic nature of
lipid diffusion with Langevin thermostat and barostat of each
simulation. Their number is larger in the replica RY200 with
respect to RX450, as expected due to the shorter time scale of
the former. Interestingly, this number significantly increases,
almost doubling, for model C which contains all three lipid
species, in both RX200 and RY450, independently on the time
scale. This is also reflected by the fact that the highest right-
most histograms in Fig. 3 are for model C in both RX450
and RY200, and fits well with the increased viscosity due to
cholesterol content. Thus, the content of cholesterol is an im-
portant bulk property of the membrane that in turn promotes
the persistence of lipid-protein binding events, for any lipid
species.
The binding sites of each lipid with persistent binding to
the receptor involved one or more protein sections (the helices
M1, M2, M3, M4, the M2-M3 loop or the Cys-loop) of one or
two adjacent subunits, and are reported in Tables II and III.
While being persistently bound to one or more specific
helices/loops, the lipid molecules involved in these binding
events can sporadically reach out for adjacent sections of the
protein as well. Both the outermost M4 helices of each subunit
and the space in-between adjacent subunits (e.g. in-between
M1 and M3 helices) give rise to convenient binding sites;
moreover, M4 helices contain CRAC and CARC motifs which
are suitable sites for binding cholesterol (as reported in Table
3 in the SI). Most lipid persistent binding is to a single helix;
however lipids, especially the two-tailed POPC and POPE,
can bind across helices, resulting in a variety of poses. Rep-




























































































TABLE II. Lipid binding sites to the receptor (replicas RX450), char-
acterised by one or more helices/loops of one or two subunits (indi-
cated as subscripts). The sites reported are only those whose corre-
sponding lipid residue has a RMSF below 3.0 Å. Selected binding


















POPE M11 M41 Fig. 4b)
M11 Fig. 4c)
CHL M13 M43
M35 M45 Fig. 4d)
M14 M35
M32
(subscripts 1 to 5 are used to label the subunits).
In model B, RX450, a cholesterol molecule is bound to M15
and to M45, and is, for a certain fraction of the simulation,
also able to partially intercalate within them to reach out for
M35 (Fig. 4 a). In model C, RX450, a POPE phospolipid
is bound to M11 and to M41, and intercalates within them to
reach out for M35 for a fraction of time with one of its tails
(Fig. 4 b), while another POPE is bound to M11, and at times
its head penetrates in the direction of the innermost M21 (Fig.
4 c), forming a hydrogen bond with Leu273 which belongs to
the M2-M3 loop and is immediately next to Pro274 which is
highly conserved through the Cys-loop superfamily, as previ-
ously mentioned;54 a cholesterol molecule is at a bound po-
sition that may lead to intercalation within the M1, M3 and
M4 of subunit 5 (Fig. 4 d). In model B, RY200, one tail of a
POPE phospolipid is able to intercalate between M12 and M33
and to reach out for the M2 helices of both subunits 2 and 3
(Fig. 4 e). In model C, RY200, a POPC phospolipid interca-
lates between M15 and M45 with one of its tails, which is at
times able to reach out for M25 (Fig. 4 f); a POPE phospolipid
binds to M1 and M4 of subunit 3, and reaches out with one of
its tails to M3 of the same subunit, thus intercalating in the
TMD, although without reaching the M2 helix (Fig. 4 g). It
is also worth mentioning that intercalation events within the
TMD also briefly occur for other, more mobile, lipids.
Overall, POPC and POPE are the lipids which intercalate
the most thanks to the length and flexibility of their tails.
It is also interesting to notice how the binding sites are sim-
TABLE III. Lipid binding sites to the receptor (replicas RY200),
characterised by one or more helices/loops of one or two subunits
(indicated as subscripts). The sites reported are only those whose
corresponding lipid residue has a RMSF below 3.0 Å. Selected bind-
ing sites are represented in Fig. 4.
Lipid Binding site
Model A, RY200
POPC M11 M2-M3 loop2
M44
M45






























ilar among the three models, this is not surprising since such
sites would be specific to the protein and to the three lipid
species investigated. However, as previously stated, a binding
event in any of these sites becomes more likely to be observed
for the model membrane with higher cholesterol contents.
POPC has been previously found to intercalate within the
TMD of membrane proteins, e.g. GLIC,33 and cholesterol
binding events were shown to occur in the adenosine recep-
tor type 2A,43 the G-protein coupled 5-HT1B receptor,44 the
GABAA receptor,27 and ELIC.31 Cholesterol, together with
POPC and SDPC, intercalation within the four helices in one
subunit of the 5-HT3A receptor was observed over many mi-
crosecond timescale. A lipid-M2 interaction was, instead, reg-
istered for the GABAA receptor, although the cholesterol bind-
ing was in this case achieved through docking rather than via
diffusion.27
At the membrane-protein interface, a variety of interactions




























































































FIG. 4. Examples of persistent lipid binding to 5-HT3AR: a) a CHL in model B; a POPE in model C; another POPE in model C; d) a CHL in
model C in RX450 (Table II). e) a POPE in model B; f) a POPC in model C; and g) a POPE in model C in RY200 (Table III)The helices are
coloured in yellow (M1), blue (M2), red (M3) and purple (M4) irrespective of the subunit they belong.
the statistical nature of how the lipid molecules diffuse, and
their random distribution around the protein, a different local
lipid environment is expected to surround each of the five re-
ceptor subunits, increasing the sampling. Lipids proximity to
the helices of the TMD is affected by membrane viscosity and
pressure, hydrogen bonds, hydrophobic effects, van der Waals
and electrostatic interactions, etc. A generic contact between
two given atoms (of two different residues) can be identified
when their distance is shorter than a given cutoff; here we used
a cut-off of 3.5 Å in agreement to previous studies.76 The av-
erage number of contacts between a given helix/loop and a
given lipid species (e.g. M1-POPC) were calculated for the
five subunits, and for the three models. Their averages over
the five subunits are shown in Fig. 5.
Fig. 6 shows the number of hydrogen bonds (averaged over
time and subunits), grouped for every lipid species and protein
section, including the four TMD helices M1, M2, M3 and M4,
the M2-M3 loop and the Cys-loop.
The M1 helices are able to form contacts with lipids, very
few of which are hydrogen bonds. Similarly, M2s form no hy-
drogen bonds, and only have sporadic contacts with the lipids,
as expected due to their position deep within the protein. As
for M3 and M4, both are able to form contacts and hydrogen
bonds with the lipids, mostly with POPC. As for the M2-M3
loop and the Cys-loop, their location puts them in the position
to interact with the upper leaflet’s heads, thus via hydrogen
bonds.
While no major differences are observed neither among
the three models nor between the averaging methods, several
interesting comments can be made regarding how hydrogen
bonds are formed between POPC, POPE, cholesterol and the
receptor. It is not surprising that most hydrogen bonds are
formed with the outermost M4 helices, while their number is
lower for the M3 and even less for the M1, both of which
lie at the interface between adjacent subunits and so are less
exposed to the membrane. The hydrogen bonds of M4 with
POPC are more frequent in model A as expected due to its
higher concentration, while the largest average number of hy-
drogen bonds with M4 is for model B, due to the increased
hydrogen bonding ability of POPE. Notably, lipid molecules
are able to reach out for the ECD, specifically interacting with
the Cys-loop, and the M2-M3 loop connecting the M2 and M3
helices. Both these structures are thought to be critical for the
receptor activation mechanism.54,77,78 The average number of
hydrogen bonds with the M2-M3 loop for any lipid species
is larger for model C and the large error bars are indicative
of the variability among subunits. As for the hydrogen bonds
with the Cys-loop, both model B and model C dominate over
model A when considering any lipid, while model A have
obviously the largest number when considering POPC alone.
POPC seems to be slightly more prone to engage in hydro-
gen bonds with the M2-M3 loop with respect to POPE, while
the opposite appear to be true for the Cys-loop. A phospho-
lipid in close proximity with the Cys-loop and the M2-M3
loop may engage in alternate, or even simultaneous hydrogen
bonds with them, thus providing a bridge between these two
key structures, as shown in the MD snapshot of Fig. 7. As




























































































FIG. 5. Number of contacts, averaged over the five subunits, between helices/loops and lipids, for RXY400 (top) and for RX400 (bottom).
Errors are calculated as standard deviations over the whole data sets at all time steps and then propagated for the five subunits.
with both the Cys-loop and the M2-M3 loop through hydro-
gen bonds than the phospolipids.
The average hydrogen bonds between the residues of these
two loops and lipids are shown in Tables 1 and 2 in the SI.
Two residues in the M2-M3 loop are particularly interesting:
Thr280, which lies next to Pro281, whose trans-cis isomeri-
sation may be linked to gating54,77,78 and formed hydrogen
bonds with lipids in each model, and Leu273, which is next
to Pro274, a highly-conserved residue within the Cys-loop
superfamily9 which may also be important for gating because
of its interaction with the β1-β2 loop.7,9,79–81 In model C,
sporadic hydrogen bonds are observed between Leu273 and
POPE in subunit 2. However, Thr280 forms hydrogen bonds
with lipids in all subunits, in particular with phospholipids,
while only interacting with cholesterol in two subunits.
IV. DISCUSSION AND CONCLUSIONS
In this work, we performed molecular dynamics simula-
tions to assess the effects of the model membrane compo-
sition at the interface with the 5-HT3A receptor, a prototypi-
cal pLGIC for which anecdotal evidence suggests sensitivity
to the lipid environment although the evidence insufficient to
draw clear conclusions.18 We compared a pure POPC model
membrane and two different mixed ones, which also include
POPE and cholesterol. These three models allowed us to dis-
tinguish the effects due to the mere presence of a lipid species
in the membrane from those due to the specific lipid concen-
tration, which spans the lower and upper limits of cholesterol
concentration in synaptic membranes.
We tested two different ways to calculate statistical aver-
ages, one with two shorter replicas, and one with a single
longer (i.e. double time) replica. Both methods gave similar
results with no significant qualitative difference. While, due to
the stochastic nature of lipid diffusion, the lipid environment
around the receptor subunits depends on the specific replica
and simulation time scale, qualitative trend can be inferred,
further enhanced by the pentameric nature of the homomeric
receptor, with five homomeric subunits in representative local
environments at any given time.
The time scales simulated here are representative of the pro-
cess of lipid diffusion and rearrangements within the mem-
brane and around this complex protein, which occur on tens
to hundreds of nanoseconds,61,62 and thus provide a meaning-
ful statistics of the lipid-protein interactions and contacts.
A variety of binding events between the protein and both
phospholipids and cholesterol were observed in the simula-
tions. The model with highest viscosity, i.e. the one with high-
est cholesterol content, also results to be the one with the high-
est number of binding events. The binding sites involved one




























































































FIG. 6. Average number of hydrogen bonds between receptor and lipids for RXY400 (top) and for RX400 (bottom). Errors are calculated as
standard deviations over the whole data sets at all time steps and then propagated for the five subunits.
and at times led to intercalation in the TMD, either within the
helices of one subunit or within the grooves between two ad-
jacent ones, potentially reaching for inner structures.
Our results highlight the relative importance of phospho-
lipids with respect to cholesterol and vice-versa, with the dif-
ferent species competing for binding. Cholesterol abundance
in the membrane affects its viscosity, while, thanks to their
higher number of suitable moieties, phospholipids form the
largest number of hydrogen bonds and are more able to inter-
calate within the protein, due to the length and/or flexibility of
their tails, more likely to reach out for out-of-hand structures
such as the Cys-loop in the ECD and the M2-M3 loop in the
TMD, possibly acting as a bridge between these structures.
The M2-M3 loop and the Cys-loop are thought to be involved
in the signalling transmission chain of events between ligand
binding and channel gating,54,77 thus are important sections of
the protein. Cholesterol is crucial: experimentally its deple-
tion affects the distribution on the cell surfaces of 5-HT3AR,
as well as of other pLGICs; it also reduces serotonin-induced
current response and desensitisation rates.18
Our study focussed on a non-conductive apo-state state
and, within the simulated time (as well as much longer time
scales26) the receptor structure was stable and did not changed
significantly.
In conclusion, we have highlighted the role of cholesterol in
tuning the properties of the membrane and therefore indirectly
promoting lipid contacts and binding events to the receptor
and giving the opportunity to phospholipids to mediate the
connection between ECD and TMD, e.g. through the Cys-
loop and the M2-M3 loop.
Although the available data are still limited to build a
definitive picture of the role played by the lipid-5-HT3AR
interactions,18 our results contribute to the understanding of
this phenomena, shedding light on the behaviour of lipids in
close proximity to the receptor at the atomistic level. A range
of other simulations can be envisaged, e.g. spanning longer
time scales, more accurate force-fields,82, different functional
states,28 a larger variety of membrane compositions or many
additional replicas starting from random initial lipid arrange-
ments. Moreover, enhanced sampling methods may be used
to induce/accelerate lipid intercalation or binding.83
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FIG. 7. A POPE lipid forms hydrogen bonds with residues of the M2-
M3 loop (in green; Gly279) and of the Cys-loop (in orange; Asp138
and Ile139) simultaneously in model B, replica RY200.
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